Has Ghulam Abbas, MD received payments from drug or device companies?

Yes. Drug and device makers reported $49,856 in general payments to Ghulam Abbas, MD across 82 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ghulam Abbas, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ghulam Abbas, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ghulam Abbas, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Charleston, WVNPI 1003887407

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (48.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Intuitive Surgical at 54.7% of the total. Reporting peaked in 2024 at $13,916 and has fallen 98.2% since, to $250 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$49,856in general payments, 2019–2025

Across 82 payments — averaging $608.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$27K
Boston Scientific$20K
Johnson & Johnson$1K
On Target Laboratories, Inc$297
Ambu Inc.$223
AstraZeneca$220
plus $703 from 8 others

$72,940in research payments, 2019–2025

Across 10 payments — averaging $7293.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

E.r. Squibb & Sons, L.L.C.$50K
AstraZeneca$23K

What the payments were for

Consulting fees$5001%
Speaking & faculty fees$18,07536%
Travel & lodging$1,8044%
Food & beverage$5,37411%
Education$24,10248%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	37	$27,272
Boston Scientific	15	$20,139
Johnson & Johnson(2 entities)	15	$1,002
On Target Laboratories, Inc	1	$297
Ambu Inc.	1	$223
AstraZeneca	3	$220
Medtronic	2	$206
Biom'up SA	1	$152
Bard Access Systems, Inc.	1	$140
BD	1	$80
Kls-martin L.p.	2	$40
Atricure, Inc.	1	$30
Surgical Specialties Corporation (US), Inc. (dba Corza Medical)	1	$28
Acera Surgical, Inc.	1	$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$49,856 in reported general payments places this provider in the 90th percentile of 30 thoracic surgery (cardiothoracic vascular surgery) providers in West Virginia.

See all thoracic surgery (cardiothoracic vascular surgery) providers in West Virginia →

Medicare billing

Part B allowed, 2024

$140,855

Medicare patients

173

Services billed

488

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lamotrigine	12	$179
Atorvastatin Calcium	13	$173
Trazodone Hcl	12	$108
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	17	$96
Oxycodone Hcl	17	$84

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Charleston

Andres Jadue TobarCharleston$20K
Robert HerronCharleston$11K
Sandeep KashyapCharleston$8K
Peter Rodgers-FischlCharleston$8K
Nathaniel KisterCharleston$8K
Ramanathan SampathCharleston$565
Mohammad KhanCharleston$12
James RankinMorgantown$1.6M
Vinay BadhwarMorgantown$56K
Seyfi TokerMorgantown$32K

See the full list for West Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →